in pictures and a few words
What it is and why it matters
Mood and the thyroid gland are linked. Depression and constant anxiety are more common in people whose thyroid is underactive or inflamed.
- This is seen in studies in people
- The thyroid can be checked with blood tests
- If it is underactive, this can be corrected
What the thyroid is linked to
Depression and constant anxiety are most strongly linked to the thyroid. So is a strong fear of social contact and of other people’s eyes.
- The link is there when the thyroid is underactive
- And when the immune system attacks the thyroid and it is inflamed
Tests can be normal
When the thyroid is inflamed, the link with depression and anxiety shows even when thyroid hormones are normal.
- The hormone used to check the thyroid can be normal
- An antibody test shows the inflammation — traces of the immune attack
- If antibodies weren’t tested, the thyroid question isn’t closed
How it works
The parts of the brain in charge of anxiety and emotional memory have many spots where thyroid hormones attach.
- Thyroid hormone affects serotonin, a substance linked to mood
- When hormones are low, these brain areas use less energy — this shows on scans
Which tests to take
Before treating “just depression”, it’s worth checking the thyroid. It takes a few blood tests.
- First depression or anxiety — the hormone used to check the thyroid
- It’s at the upper limit, or symptoms persist on treatment — the thyroid hormones themselves
- Depression doesn’t lift on treatment — antibodies, even with a normal hormone
When a hormone is added
If two courses of antidepressants haven’t helped, a psychiatrist may add the active thyroid hormone to them.
- In a study, depression nearly went away in some of these people
- The hormone was easier to tolerate than another medicine used for the same purpose
- It is added to the main treatment, not used instead of it
Important. Don’t add thyroid hormones on your own — only under the care of a psychiatrist and an endocrinologist: with a poorly matched dose, palpitations and mood swings are possible.
Who should see a doctor first
It’s worth checking your thyroid with a doctor if:
- This is your first depression or anxiety and the thyroid hasn’t been checked yet
- Two courses of antidepressants haven’t helped — discuss it with a psychiatrist and an endocrinologist
- You have depression or anxiety, and you or your relatives have an inflamed thyroid
Important. Depression after childbirth is a reason to get thyroid tests as part of the usual check-up, not instead of it.
What not to do
The thyroid is one of the factors, not the only cause. It’s important not to go too far either way.
- Don’t expect fixing the thyroid to replace care from a psychiatrist
- Don’t blame every bit of tiredness and low mood on the thyroid without tests
In one sentence
Depression and anxiety are linked to the thyroid, and when it’s inflamed, even when hormones are normal. Check it with tests and get treated together with a psychiatrist: the thyroid adds to treatment, it doesn’t replace it.
Key points
The link between thyroid disease and mental health replicates across case-control studies and systematic reviews; the essentials are in the table.
| Situation | How it helps | What human studies showed |
|---|---|---|
| Depression and anxiety in Hashimoto’s with normal TSH and fT4 | a TPO antibody test finds an autoimmune component invisible on TSH | case-control, 19 patients with Hashimoto’s in the euthyroid phase: lifetime OR for depressive episode 6.6 (95% CI 1.2–25.7), GAD 4.9 (1.5–25.4), social phobia 20.0 (2.3–153.3) — independent of thyroid function (Carta 2005) |
| Hypothyroidism — clinical and subclinical | TSH at a first episode of depression or anxiety finds a correctable factor: hypothyroidism is fully reversible with correction | a 2021 meta-analysis confirmed the link between clinical hypothyroidism and depression at the population level; in subclinical — odds ratios of 1.78–3.56 depending on the cohort, higher in patients under 60 |
| Treatment-resistant depression after two failed antidepressant courses | T3 (liothyronine, up to 50 mcg/day) added to an antidepressant, prescribed by a psychiatrist | in STAR*D, remission 24.7% on T3 versus 15.9% on lithium; T3 was better tolerated (Nierenberg 2006) |
How it helps
Thyroid status is one measurable, correctable factor shaping the clinical picture, alongside whatever psychiatric treatment is already in place.
Depression and anxiety
The most consistently replicated pair is major depressive disorder and generalized anxiety disorder (GAD). In a classic case-control study (19 patients with Hashimoto disease in the euthyroid phase, 19 with euthyroid goitre, two control groups of 76 each, DSM-IV diagnoses), patients with Hashimoto disease more often had a lifetime depressive episode, GAD and social phobia (odds ratios in the table above).
The key detail: the association held independent of thyroid function — that is, in patients with no functional thyroid impairment at the time of study (Carta MG, et al. Clin Pract Epidemiol Ment Health 2005;1:23. PMID 16285879).
A larger 2021 systematic review and meta-analysis confirms the association between clinical hypothyroidism and depression at the population level (PMID 34524390), while meta-analyses of subclinical hypothyroidism show odds ratios ranging from 1.78 to 3.56 depending on the cohort, with a stronger association in patients under 60.
How it works
Thyroid hormone receptors are found in high density precisely in the amygdala and hippocampus — structures governing anxiety regulation and emotional memory. T3 modulates serotonergic signaling: it desensitizes 5-HT1A autoreceptors in the raphe nuclei (which should increase serotonin availability) and increases postsynaptic 5-HT2 receptor sensitivity (Hage MP, Azar ST. J Thyroid Res 2012;2012:590648. PMID 22220285).
In hypothyroidism, this mechanism runs in reverse: reduced thyroid signaling in the limbic system is associated with reduced glucose metabolism in the amygdala and anterior cingulate cortex on PET imaging — regions involved in stress response and affective states.
Hashimoto’s with normal labs
The practical takeaway from the Carta study is that the depression/anxiety link with Hashimoto thyroiditis does not require impaired thyroid function. The presence of TPO antibodies itself is associated with elevated risk, independent of TSH and fT4.
This changes the diagnostic algorithm: in a patient with treatment-resistant depression or anxiety, a normal TSH does not close the question of thyroid involvement — if TPO antibodies were never checked, the autoimmune component remains unexamined. For the full driver-checking algorithm in autoimmune thyroiditis, see low-dose naltrexone (LDN) in Hashimoto thyroiditis.
When T3 boosts an antidepressant
In the STAR*D trial (Sequenced Treatment Alternatives to Relieve Depression), patients who had failed two antidepressant trials were augmented with either lithium or T3 (liothyronine, up to 50 mcg/day). Remission on T3 was 24.7% versus 15.9% on lithium, with T3 better tolerated and less often discontinued for side effects (Nierenberg AA, et al. Am J Psychiatry 2006;163:1519–1530. PMID 16946176).
This is a third-line augmentation strategy, prescribed by a psychiatrist after two antidepressant trials have failed — not a replacement for first-line therapy and not self-treatment for a first episode of low mood.
What to check
A patient has been on antidepressants for five years without lasting benefit. Medication switched, dose adjusted, second-line therapy tried — partial improvement at best. The question nobody asked: was a full thyroid panel, including TPO antibodies, ever run, or just TSH at a routine physical three years ago?
▸TSH — baseline screening for any first depressive or anxiety episode. ▸Free T4 and free T3 — for borderline-high TSH or persistent symptoms on therapy. ▸TPO antibodies, Tg antibodies — mandatory in treatment-resistant depression/anxiety, even with normal TSH (see euthyroid Hashimoto's above). ▸Reverse T3, selenium, ferritin — when functional hypothyroidism is suspected, covered in T4 → T3 conversion and functional hypothyroidism.
Without this panel, a subset of patients receive years of psychiatric treatment alone while a correctable endocrine component goes unaddressed.
Who should see a doctor first
▸A first depressive or anxiety episode without a prior thyroid panel. ▸Treatment-resistant depression after two antidepressant trials — discuss T3 augmentation with a psychiatrist and endocrinologist. ▸Anxiety or depression with a known Hashimoto's diagnosis or family history of autoimmune thyroiditis. ▸Depressive symptoms postpartum — a thyroid panel as part of, not a replacement for, standard workup.
Common mistakes
▸Attributing any fatigue or low mood to the thyroid without lab confirmation — overdiagnosis is as harmful as underdiagnosis. ▸Self-adding T3 or NDT to antidepressants without psychiatric and endocrine supervision — risk of tachycardia and mood instability at an uncontrolled dose. ▸Expecting TSH correction to fully replace psychiatric treatment — thyroid status is one contributing factor, not the sole cause of the clinical picture.
Bottom line
Depression and generalized anxiety disorder are statistically linked to hypothyroidism and, separately, to Hashimoto’s — even at normal thyroid function. T3 is a confirmed third-line augmentation therapy in treatment-resistant depression. These findings do not replace psychiatric care; they add to it a measurable, correctable endocrine component that TSH+fT4 screening without TPO antibodies can miss.
I perform a comprehensive thyroid assessment (TSH, fT4, fT3, TPO antibodies, Tg antibodies) in the context of the psychiatric picture and coordinate a correction protocol together with the treating psychiatrist.
Sources
▸Carta MG, Hardoy MC, Carpiniello B, et al. A case control study on psychiatric disorders in Hashimoto disease and euthyroid goitre. Clin Pract Epidemiol Ment Health 2005;1:23. PMID 16285879 ▸Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res 2012;2012:590648. PMID 22220285 ▸Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006;163:1519–1530. PMID 16946176 ▸Association of Hypothyroidism and Clinical Depression: A Systematic Review and Meta-analysis. 2021. PMID 34524390 ▸Postpartum depression in maternal thyroidal changes: a systematic review. 2022. PMID 35351167
Related articles: T4 → T3 conversion and functional hypothyroidism, Low-dose naltrexone (LDN) in Hashimoto thyroiditis, Hypothyroidism and natural desiccated thyroid (NDT).
Key facts
- Depression and generalized anxiety disorder are the most consistently replicated mental-health link to hypothyroidism and Hashimoto’s, and thyroid status is one of the measurable, correctable factors.
- Case-control (Carta 2005): lifetime OR 6.6 for depression, 4.9 for GAD, 20.0 for social phobia in euthyroid Hashimoto’s.
- The link persists with normal TSH and fT4 — the presence of TPO antibodies itself is associated with elevated risk.
- STAR*D: adding T3 to an antidepressant after two failed courses produced 24.7% remission versus 15.9% on lithium, with better tolerability.
- Thyroid hormone receptors are dense in the amygdala and hippocampus; T3 modulates serotonergic signaling.




